Results 191 to 200 of about 229,203 (309)
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis. [PDF]
Wakolbinger R +8 more
europepmc +1 more source
CAQ Corner: Basic concepts of transplant immunology
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley +1 more source
Mesenchymal Stem Cells and Their Derived Exosomes Mitigated Hepatic Cirrhosis in Rats by Altering the Expression of miR-23b and miR-221. [PDF]
Abd-Allah SH +5 more
europepmc +1 more source
Correction to: Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis. [PDF]
Wakolbinger R +8 more
europepmc +1 more source
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott +10 more
wiley +1 more source
CAQ Corner: Immune‐mediated complications
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley +1 more source
Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis. [PDF]
Zhang L +4 more
europepmc +1 more source
Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. [PDF]
Marino, Ignazio Roberto +1 more
core

